Vireo Growth to acquire four Ohio cannabis companies for ~$210M in stock

Vireo Growth Inc.

Acquires FarmaceuticalRx LLC for ~$139.5M in stock; FRX has $23.8M closing EBITDA.
Acquires FarmaceuticalRx2 LLC for ~$19.2M in stock (after adjustments) plus assumes ~$50.9M debt.
Acquires Canoe Hill Ohio for ~$34.8M in stock (5.7x $6.1M EBITDA) and CAOH for ~$16.0M in stock (5.7x $2.8M EBITDA).
CEO John Mazarakis is a seller in CAOH transaction (related party); will receive 421,344 shares, increasing his stake by 128.5%.
All deals include performance-based clawback: up to 25% of shares forfeited if 2027 EBITDA targets missed and stock price >$31.50.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.